Brief: Dynavax Announces Great Britain Marketing Authorization For Heplisav B, A Two-Dose Adult Hepatitis B Adjuvanted Vaccine
28/02/2023 13:21
Feb 28 (Reuters) - Dynavax Technologies Corp DVAX.O :
* DYNAVAX ANNOUNCES GREAT BRITAIN MARKETING AUTHORIZATION
FOR
HEPLISAV B, A TWO-DOSE ADULT HEPATITIS B ADJUVANTED VACCINE
Source text for Eikon: ID:nPn2tmsmWa
Further company coverage: DVAX.O
Recent news on Dynavax Technologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
OneSpaWorld jumps as co poised to join S&P SmallCap index
Sanofi targets high single digit sales growth in 2026, plans share buyback (updated)
Focus: Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality